Research Topics
Species | Maryl R JohnsonSummaryAffiliation: University of Wisconsin Country: USA Publications
| Collaborators
|
Detail Information
Publications
When is retransplantation a viable option?Maryl R Johnson
University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA
Heart Fail Clin 3:97-105. 2007..Relative contraindications to transplantation (ie, advanced age, comorbidities, psychosocial issues) require thorough assessment when retransplantation is being considered...
Heart retransplantationM R Johnson
University of Wisconsin, Madison, WI, USA
Am J Transplant 7:2075-81. 2007..In addition, guidelines established for primary transplant candidacy should be strictly followed...
Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experienceSatoru Osaki
Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA
Eur J Cardiothorac Surg 34:281-8. 2008..The purpose of this study is to analyze the impact of these changes in care at our center over the last 17 years...
Decreased T-cell responses to influenza vaccination in patients with heart failureOrly Vardeny
University of Wisconsin, Madison, 53705 2222, USA
Pharmacotherapy 30:10-6. 2010..To determine whether T-cell immune responses to influenza vaccination in patients with chronic heart failure (CHF) are less vigorous than the responses of healthy control subjects...
Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapyMargaret A Murray
Department of Surgery, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
Interact Cardiovasc Thorac Surg 8:84-8. 2009..1/13 patients, P<0.01). A multidisciplinary approach significantly decreased LOS and cost after VAD therapy, mostly by decreasing the cost of routine non-ICU care, without increasing the readmission rate...
To explant or not to explant: an invasive and noninvasive monitoring protocol to determine the need of continued ventricular assist device supportSatoru Osaki
Department of Surgery, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792 3236, USA
Congest Heart Fail 15:58-62. 2009..This patient was transplanted. This current experience of VAD weaning protocol is a novel tool to identify candidates for successful VAD explantation...
Management of allosensitized cardiac transplant candidatesMauricio Velez
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
Transplant Rev (Orlando) 23:235-47. 2009..Serial post-transplantation PRAs may be advisable in patients at high risk of de novo allosensitization...
The potential of cardiac allografts from donors after cardiac death at the University of Wisconsin Organ Procurement OrganizationSatoru Osaki
Department of Surgery, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792 3236, USA
Eur J Cardiothorac Surg 37:74-9. 2010..The purpose of this study is to investigate the potential availability of hearts from adult donation after cardiac death (DCD) donors within an acceptable hypoxic period...
A novel use of the implantable ventricular assist device for isolated right heart failureSatoru Osaki
Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792 3236, USA
Interact Cardiovasc Thorac Surg 7:651-3. 2008..The patient has no recurrence of heart failure 668 days after RVAD explantation...
Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist deviceSatoru Osaki
Department of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792 3236, USA
J Heart Lung Transplant 27:353-6. 2008..On Day 41 post-operatively, radiofrequency ablation was performed. Two significant areas of scarring were identified and were successfully ablated. After ablation, he did not have significant sustained VT episodes and was discharged...
The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blockerOrly Vardeny
University of Wisconsin School of Pharmacy, Pharmacy Practice Division, Madison, WI 53705 2222, USA
J Cardiovasc Pharmacol 52:500-6. 2008..Future studies are needed to confirm whether treatment with carvedilol may be associated with decreased insulin and insulin resistance in beta2-AR codon 27 Gln carriers...
Decreased immune responses to influenza vaccination in patients with heart failureOrly Vardeny
University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705 2222, USA
J Card Fail 15:368-73. 2009..Both humoral (antibody) and cytotoxic T-lymphocyte (CTL) responses are important for protection. We explored antibody- and CTL-mediated responses to the influenza vaccine in HF patients compared with healthy controls...
Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experienceSatoru Osaki
Department of Surgery, Division of Cardiothoracic Surgery, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792 3236, USA
J Heart Lung Transplant 28:591-7. 2009..In this study we document our institutional long-term results and recent improvements in BTT therapy...
Heart transplantation in the United States, 1999-2008M R Johnson
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Am J Transplant 10:1035-46. 2010..With the rise in infant candidates for transplantation and their high waiting list mortality, better means of supporting infants in need of transplant and allocation of organs to infant candidates is clearly needed...
Eosinophilic myocarditis in the explanted hearts of cardiac transplant recipients: Interesting pathologic finding or pathophysiologic entity of clinical significance?Maryl R Johnson
Crit Care Med 32:888-90. 2004
